Bispecific CAR-iNKT cells : beyond dual antigen targeting

Simonetta, Federico

doi:10.1182/blood.2025030952

Scientific article

Editorial

English

Bispecific CAR-iNKT cells : beyond dual antigen targeting

ContributorsSimonetta, Federico

Published inBlood, vol. 147, no. 2, p. 100-101

Publication date2026-01-08

Abstract

Comment on : Ren H, Elliott N, Lye B, Sharif Shohan MU, Cross JW, Field L, Ponnusamy K, Rice S, Jackson T, Leontari I, El Ouazzani N, Thomas R, Inglott S, Bartram J, Smith O, Bond J, Roberts IAG, Halsey C, Bashford-Rogers R, Milne TA, Roy A, Karadimitris A. Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia. Blood. 2026 Jan 8;147(2):180-196. doi: 10.1182/blood.2025029302. PMID: 40898981; PMCID: PMC12824662.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Thérapie cellulaire et transplantation (1054)

Citation (ISO format)

SIMONETTA, Federico. Bispecific CAR-iNKT cells : beyond dual antigen targeting. In: Blood, 2026, vol. 147, n° 2, p. 100–101. doi: 10.1182/blood.2025030952

Article (Published version)

Identifiers

PID : unige:194539
DOI : 10.1182/blood.2025030952
PMID : 41505150

Additional URL for this publicationhttps://ashpublications.org/blood/article/147/2/100/557539/Bispecific-CAR-iNKT-cells-beyond-dual-antigen

Journal ISSN0006-4971

2views

47downloads

Creation16/06/2026 08:48:54

First validation09/07/2026 07:06:20

Update09/07/2026 07:06:20

Status update09/07/2026 07:06:20

Last indexation09/07/2026 07:06:21

Archive ouverte UNIGE

Bispecific CAR-iNKT cells : beyond dual antigen targeting

Technical informations